May 9 (Reuters) – Valeant Pharmaceuticals International Inc
said on Monday it expects to file its first-quarter
report with the regulators on or before June 10, ahead of the
July 31 deadline.
The post Valeant says will file its quarterly report by June 10 appeared first on NASDAQ.